Kiran Mazumdar-Shaw on Biocon Q1 results: Our biz must be viewed on core EBITDA as R&D spend is an integral part of future growth28 Jul, 2022, 01.27 PM ISTBiocon Q4 net profit at Rs 113 crore, sales up 15%25 Apr, 2014, 11.27 AM ISTSpaceX surges past Amazon, Microsoft: Why are Elon Musk-led company's stocks, valuation rising?
A World War II-era drug just helped patients go from 7 bathroom trips a night to just one
'Tamil Nadu pollution board finds no contamination at Hosur iPhone parts facility': Tata Electronics
US stocks: Nasdaq and S&P 500 slip while Dow hits record high ahead of Fed rate decision
Public-private projects key to expand access to Kidney care: NephroPlus
SC's ₹30,000 homemaker benchmark may lift accident compensation payouts
Areion seeks RBI approval for Rs 936 crore Aviom takeover
API prices fall as West Asia tensions ease, boosting Indian pharma sector
FIFA World Cup: Heavyweights stumble as minnows make their mark on the global stage
HDFC Bank board to review findings on Atanu Chakraborty's exit on June 18
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service